Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Cancer Survivorship
Erschienen in: Journal of Cancer Survivorship 4/2010

01.12.2010

Fear of cancer recurrence: specific profiles and nature of intrusive thoughts

verfasst von: Sébastien Simard, Josée Savard, Hans Ivers

Erschienen in: Journal of Cancer Survivorship | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Although the fear of cancer recurrence (FCR) is to varying degrees almost universal in cancer survivors, few studies have been carried out specifically on this issue partly because of the complexity and the heterogeneity of the phenomenon.

Purpose

To explore the presence of specific profiles of FCR and to describe the nature of intrusive thoughts associated with FCR.

Methods

A medical database was used to randomly select a large pool of French-Canadian patients who had been treated for breast, prostate, lung, or colorectal cancer within the past ten years. A sample of 1 984 participants completed, by mail, the Fear of Cancer Recurrence Inventory (FCRI) and the Cognition Intrusive Questionnaire (CIQ).

Results

Cluster analysis revealed four distinct groups of FCR patients: Mild FCR-Low Copers, Mild FCR-High Copers, Moderate FCR-High Copers and High FCR-High Copers. Percentages of endorsement obtained on CIQ items suggested that intrusive thoughts associated with FCR share many characteristics with worries (i.e., egosyntonic, verbal content). However, intrusive thoughts associated with High FCR presented more characteristics of obsessions.

Conclusion

There are different profiles of FCR, which vary according to its severity and the type of coping strategies used. Characteristics of intrusive thoughts associated with FCR suggested different targets for FCR specific intervention.
Literatur
1.
Vickberg SM. The Concerns About Recurrence Scale (CARS): A systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25:16–24.CrossRefPubMed
2.
Deimling GT, Bowman KF, Sterns S, et al. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15:306–20.CrossRefPubMed
3.
Hodges LJ, Humphris GM. Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psychooncology. 2009;18:841–8.CrossRefPubMed
4.
Llewellyn CD, Weinman J, McGurk M, Humphris G. Can we predict which head and neck cancer survivors develop fears of recurrence? J Psychosom Res. 2008;65:525–32.CrossRefPubMed
5.
Mehta SS, Lubeck DP, Pasta DJ, Litwin MS. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: Results from CaPSURE. J Urol. 2003;170:1931–3.CrossRefPubMed
6.
Skaali T, Fossa SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psychooncology. 2009;18:580–8.CrossRefPubMed
7.
Stanton AL, Danoff-Burg S, Huggins ME. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psychooncology. 2002;11:93–102.CrossRefPubMed
8.
Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104:2565–76.CrossRefPubMed
9.
Hodgkinson K, Butow P, Fuchs A, et al. Long-term survival from gynecologic cancer: Psychosocial outcomes, supportive care needs and positive outcomes. Gynecol Oncol. 2007;104:381–9.CrossRefPubMed
10.
Bellizzi KM, Latini DM, Cowan JE, et al. Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology. 2008;72:1269–73.CrossRefPubMed
11.
Humphris GM, Rogers S, McNally D, et al. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg. 2003;32:486–91.PubMed
12.
Mellon S, Northouse LL, Weiss LK. A population-based study of the quality of life of cancer survivors and their family caregivers. Cancer Nurs. 2006;29:120–31.CrossRefPubMed
13.
Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17:241–51.CrossRefPubMed
14.
van den Beuken-van Everdingen MHJ, Peters ML, de Rijke JM, et al. Concerns of former breast cancer patients about disease recurrence: A validation and prevalence study. Psychooncology. 2008;17:1137–45.CrossRefPubMed
15.
Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In: Rachman S, editor. Contributions to medical psychology. Edition New York: Pergamon Press; 1980. p. 7–30.
16.
Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence - A literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6:95–105.CrossRefPubMed
17.
Baider L, De-Nour AK. Psychological distress and intrusive thoughts in cancer patients. J Nerv Ment Dis. 1997;185:346–8.CrossRefPubMed
18.
Manne S, Glassman M, Du Hamel K. Intrusion, avoidance, and psychological distress among individuals with cancer. Psychosom Med. 2001;63:658–67.PubMed
19.
Mehnert A, Koch U. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: A prospective study. Psychooncology. 2007;16:181–8.CrossRefPubMed
20.
Kangas M, Henry JL, Bryant RA. The relationship between acute stress disorder and posttraumatic stress disorder following cancer. J Consul Clin Psychol. 2005;73:360–4.CrossRef
21.
Lebel S, Rosberger Z, Edgar L, Devins GM. Comparison of four common stressors across the breast cancer trajectory. J Psychosom Res. 2007;63:225–32.CrossRefPubMed
22.
McNally RJ. Progress and controversy in the study of posttraumatic stress disorder. Annu Rev Psychol. 2003;54:229–52.CrossRefPubMed
23.
Whitaker KL, Brewin CR, Watson M. Intrusive cognitions and anxiety in cancer patients. J Psychosom Res. 2008;64:509–17.CrossRefPubMed
24.
Whitaker KL, Watson M, Brewin CR. Intrusive cognitions and their appraisal in anxious cancer patients. Psychooncology. 2009;18:1147–55.CrossRefPubMed
25.
Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology 2009.
26.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Texte revision. Washington: American Psychiatric Association; 2000.CrossRef
27.
Borkovec TD, Robinson E, Pruzinsky T, DePree JA. Preliminary exploration of worry: Some characteristics and processes. Behav Res Ther. 1983;21:9–16.CrossRefPubMed
28.
Clark DA, Rhyno S. Unwanted Intrusive Thoughts in Nonclinical Individuals: Implications for Clinical Disorders. In: Clark DA, editor. Intrusive Thoughts in Clinical Disorders. Theory, Research and Treatment, Edition New York, NY: The Guilford Press; 2005. p. 1–29.
29.
Wells A, Morrison AP. Qualitative dimensions of normal worry and normal obsessions: A comparative study. Behav Res Ther. 1994;32:867–70.CrossRefPubMed
30.
Langlois F, Ladouceur R, Patrick G, Freeston MH. Characteristics of illness intrusions in a non-clinical sample. Behav Res Ther. 2004;42:683–96.CrossRefPubMed
31.
Freeston MH, Ladouceur R, Thibodeau N, Gagnon F. Cognitive intrusions in a non-clinical population: II. Associations with depressive, anxious, and compulsive symptoms. Behav Res Ther. 1992;30:263–71.CrossRefPubMed
32.
Freeston MH, Ladouceur R. Appraisal of cognitive intrusions and response style: Replication and extension. Behav Res Ther. 1993;31:185–91.CrossRefPubMed
33.
Clark DA. Intrusive thoughts in clinical disorders: Theory, research and treatment. New York: The Guilford Press; 2005.
34.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefPubMed
35.
SPSS. Statistical package for the social sciences. In Edition Chicago, IL: SPSS Corporation 1999.
36.
National Cancer Institute of Canada. Canadian Cancer Statistics. Toronto: National Cancer Institute of Canada; 2003.
37.
Tabachnik BG, Fidell LS. Using multivariate statistics. New York: Harper Collins Publishers; 2001.
38.
SAS Institute. Sas/stat 9.1 user's guide. Cary: SAS Institute; 2004.
39.
Hair Jr JF, Black WC. Cluster analysis. In: Grimm LG, Yarnold PR, editors. Reading and. Understanding More Multivariate Statistics, Edition Washington, D.C.: American Psychological Association; 2000. p. 147–205.
40.
Mellon S, Kershaw TS, Northouse LL, Freeman-Gibb L. A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psychopncology. 2007;16:214–23.CrossRef
41.
Hartl K, Janni W, Kastner R, et al. Long-term quality of life, body image and anxiety in women after breast cancer. Geburtshilfe Frauenheilkund. 2003;63:446–52.CrossRef
42.
Steginga SK, Occhipinti S, McCaffrey J, Dunn J. Men's attitudes toward prostate cancer and seeking prostate-specific antigen testing. J Cancer Educ. 2001;16:42–5.PubMed
43.
Lee HJ, Lee SH, Kim HS, et al. A comparison of autogenous/reactive obsessions and worry in a nonclinical population: A test of the continuum hypothesis. Behav Res Ther. 2005;43:999–1010.CrossRefPubMed
44.
Wade TD, Nehmy T, Koczwara B. Predicting worries about health after breast cancer surgery. Psychooncology. 2005;14:503–9.CrossRefPubMed
45.
Moore EL, Abramowitz JS. The cognitive mediation of thought-control strategies. Behav Res Ther. 2007;45:1949–55.CrossRefPubMed
46.
Dugas MJ, Ladouceur R. Treatment of GAD: Targeting intolerance of uncertainty in two types of worry. Behavior Modification. 2000;24:635–357.CrossRefPubMed
47.
Clark DA, O'Connor K. Thinking is believing: Ego-dystonic intrusive thoughts in obsessive-compulsive disorder. In: Clark DA, editor. Intrusive thoughts in clinical disorders: Theory, research and treatment. New York: The Guilford Press; 2005. p. 175–98.
48.
Herschbach P, Duran G, Engst-Hastreiter U, et al. Group therapy for fear of progression in cancer patients. Verhaltenstherapie & Verhaltensmedizin. 2006;27:298–309.
49.
Humphris G, Ozakind G. The AFTER intervention: A structured psychological approach to reduce fears of recurrence in patients with head and neck cancer. Br J Health Psychol. 2008;13:223–30.CrossRefPubMed
Metadaten
Titel
Fear of cancer recurrence: specific profiles and nature of intrusive thoughts
verfasst von
Sébastien Simard
Josée Savard
Hans Ivers
Publikationsdatum
01.12.2010
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 4/2010
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0136-8

Weitere Artikel der Ausgabe 4/2010

Journal of Cancer Survivorship 4/2010 Zur Ausgabe

OriginalPaper

The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer

OriginalPaper

Predictors and course of chronic fatigue in long-term breast cancer survivors

OriginalPaper

Social networks and survival after breast cancer diagnosis

OriginalPaper

Mental health among young adult survivors of childhood cancer and their siblings including posttraumatic growth

ReviewPaper

Psychological interventions for the sexual sequelae of cancer: A review of the literature

OriginalPaper

Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise